If you’re a discerning professional who would prefer to see children and adolescents grow up drug-free rather than in a chemical haze, you are being encouraged to contact NICE, become a stakeholder on the ADHD guidelines and submit your comments.
The notoriety is exemplified by the manufactured psychiatric label ‘Attention Deficit Hyperactivity Disorder’ (ADHD). Once confined to children and adolescents in the classroom, it has through clever marketing techniques, become commonplace to find adults being told they too have the so-called condition.
Now according to the Telegraph, the National Institute of Health and Care Excellence (NICE) is claiming girls and women are going undiagnosed because they are less likely to have “classic” symptoms of the disorder. It’s music to the ears of those who stand to profit from increased diagnoses as this would likely result in increased drug sales.
An updated draft guideline and supporting evidence has been put out by NICE for consultation which includes the controversial issue. The brazen wording states, “Be aware that ADHD is thought to be under-recognised in girls and women” as they are:
- less likely to be referred for assessment for ADHD
- more likely to have undiagnosed ADHD
- more likely to receive an incorrect diagnosis of another mental health or neurodevelopmental condition
It cannot be stressed too often; the diagnostic criteris for ADHD is synonymous with normal behaviour. It’s important to realise that what psychiatrists have done is to take a set of emotional and behavioural characteristics and redefine them. Whichever way you look at it, it’s not science – it’s opinion.
This would perhaps be more accurate; be aware that ADHD is thought to be psychiatric opinion and representative of normal behaviour in boys, girls, men and women.
- Do not advise elimination of artificial colouring and additives from the diet as a generally applicable treatment for children and young people with ADHD
Why not? It also takes a swipe at other natural dietary additions that could be helpful. It states:
- Do not advise or offer dietary fatty acid supplementation for treating ADHD in children and young people
It does however state the following:
Offer methylphenidate as first line pharmacological treatment for children aged 5 years and overand young people with ADHD
Psychiatric drugs, pharmacologically similar to cocaine and classified as Class B drugs by the Government, are being pushed while sensible dietary habits in a modern world are being gently dismissed. It is an intolerable situation that smacks of vested interests.
ADHD drugs dispensed in England between 2000 and 2016, have cost the NHS over £588 million. When you understand ADHD has never been scientifically proven, and when you realise it was voted into existence by a show of hands in 1987, it represents good business but it’s bad medicine.
The consultation on the draft guideline will close at 5pm on 18 October 2017. Any discerning professionals who would prefer to see children and adolescents grow up drug-free rather than in a chemical haze are encouraged to contact NICE, become a stakeholder on the guidelines and submit their comments.
You can also contact CCHR UK for more information.
Further reading: Psychostimulants: the facts about the effects